Losartan is the only angiotensin II receptor blocker that has shown to significantly lower uric acid levels. The addition of or switch to losartan as an antihypertensive agent for patients with gout is recommended by clinical guidelines because of its benefit as a uricosuric agent.
Maha Saad. Hyperuricemia and Gout: The Role of Losartan. The Senior care pharmacist. 2023 Sep 01;38(9):359-360
PMID: 37612850
View Full Text